GlassScriptPhysician profile
Shashi A Patel
NPI 1306868161
$3,324.67
in general payments reported to CMS, 2019-2025
23 companies · $29.07 in 2025
The $29.07 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,199 · 2020: $736 · 2021: $1,043 · 2022: $125 · 2023: $193 · 2025: $29.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $222.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,006.76 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $609.57 | 2019-2021 | |
| Insmed, INC. | $287.68 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $237.09 | 2019-2021 | |
| Abbott Laboratories | $175.00 | 2023 | Xience Sierra |
| Pfizer INC. | $141.49 | 2019 | |
| Vyaire Medical, INC. | $125.14 | 2019 | |
| Circassia INC. | $94.45 | 2019-2020 | |
| Electromed, INC. | $69.45 | 2019-2023 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $61.90 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $61.13 | 2019-2021 | |
| Mylan Specialty L.P. | $57.42 | 2019-2021 | |
| Philips North America LLC | $52.39 | 2019-2020 | |
| Abbvie INC. | $47.73 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $44.33 | 2020-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $41.84 | 2019 | |
| Optinose US, INC. | $39.98 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $38.59 | 2021 | |
| Advanced Respiratory, INC | $33.76 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.38 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $31.19 | 2019 | |
| Novo Nordisk INC | $17.50 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $16.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shashi Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.